---
title: Eeva™ Pregnancy Pilot Study (PPS)
nct_id: NCT02218255
overall_status: UNKNOWN
phase: NA
sponsor: Progyny, Inc.
study_type: INTERVENTIONAL
primary_condition: Infertility
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02218255.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02218255"
ct_last_update_post_date: 2015-10-20
last_seen_at: "2026-05-12T06:45:09.185Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Eeva™ Pregnancy Pilot Study (PPS)

**NCT ID:** [NCT02218255](https://clinicaltrials.gov/study/NCT02218255)

## Key Facts

- **Status:** UNKNOWN
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 240
- **Lead Sponsor:** Progyny, Inc.
- **Conditions:** Infertility
- **Start Date:** 2014-08
- **Completion Date:** 2016-06
- **CT.gov Last Update:** 2015-10-20

## Brief Summary

The purpose of this clinical investigation is to gather pilot data to evaluate the impact of using Eeva™, a time-lapse enabled embryo test, in combination with traditional morphology on clinical pregnancy rates.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 40 Years
- **Sex:** FEMALE
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Women undergoing fresh in vitro fertilization treatment using their own eggs
* ≤ 40 years
* ≥ 4 diploid embryos (i.e. having 2 PNs)
* ≤ 3 Prior ART cycles (IVF, ICSI and related procedures)
* All 2PN embryos (for all 3 arms) must be imaged by Eeva
* Subject willing to comply with study protocol and procedures
* Subject willing to provide written informed consent

Exclusion Criteria:

* Preimplantation genetic diagnosis or preimplantation genetic screening
* Planned "freeze all" cycle (eggs or embryos)
* Asherman's Syndrome
* Donor egg
* Gestational carrier
* Presence of Hydrosalpinx on ultrasound
* Concurrent participation in an interventional clinical study
```

## Arms

- **Day 3 eSET combined with Eeva** (ACTIVE_COMPARATOR) — Traditional Morphology + Eeva™ results
- **Day 5 eSET combined with Eeva** (ACTIVE_COMPARATOR) — Traditional Morphology + Eeva™ results
- **Day 5 eSET with Traditonal Morphology** (NO_INTERVENTION)

## Interventions

- **Eeva™ results** (DEVICE)

## Primary Outcomes

- **Clinical Pregnancy** _(time frame: 7-8 weeks gestation)_

## Secondary Outcomes

- **Ongoing pregnancy rate** _(time frame: 8-12 week gestation)_

## Locations (1)

- Brigham and Women's Hospital, Boston, Massachusetts, United States — _RECRUITING_

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.brigham and women's hospital|boston|massachusetts|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02218255.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02218255*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*